Marko Skelin
Impact in
-
- Thyroid Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Kruppel-like factors research 3
- Genetics 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Co-authors
- Tomo Lucijanić (7 shared papers)Dario Rahelić (7 shared papers)Marko Lucijanić (11 shared papers)Hossein Gharib (1 shared paper)Daniela Amidžić Klarić (1 shared paper)Rajko Kušec (2 shared papers)Vlatko Pejša (2 shared papers)Ivica Lukšić (3 shared papers)
- Journals
- International Journal of Clinical Practice (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)Pharmacology (1 paper)International Journal of Cardiology (1 paper)Anticancer Research (1 paper)
- Partner nations
- CroatiaUnited StatesIreland
In The Last Decade
Marko Skelin
22 papers receiving 262 citations
Peers
Comparison fields: 5 of 72
- Endocrinology, Diabetes and Metabolism 84
- Genetics 50
- Otorhinolaryngology 19
- Internal Medicine 16
- Geriatrics and Gerontology 12
Countries citing papers authored by Marko Skelin
This map shows the geographic impact of Marko Skelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Skelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Skelin more than expected).
Fields of papers citing papers by Marko Skelin
This network shows the impact of papers produced by Marko Skelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Skelin. The network helps show where Marko Skelin may publish in the future.
Co-authors
The 22 scholars most cited alongside Marko Skelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 82 | |
| 2 | 2018 | 30 | |
| 3 | 2018 | 28 | |
| 4 | 2018 | 21 | |
| 5 | 2019 | 21 | |
| 6 | 2017 | 20 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 11 | |
| 9 | 2021 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2018 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2022 | 1 | |
| 20 | Scurvy. | 2022 | 1 |
About Marko Skelin
Marko Skelin is a scholar working on Molecular Biology, Genetics, Hematology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 25 papers that have together received 270 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Metabolism, Diabetes, and Cancer (3 papers), Kruppel-like factors research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Head and Neck Cancer Studies (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Lung Cancer Research Studies (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (84 citations), Genetics (50 citations), Otorhinolaryngology (19 citations), Internal Medicine (16 citations) and Geriatrics and Gerontology (12 citations). Marko Skelin has collaborated with scholars based in Croatia, United States and Ireland. Frequent co-authors include Tomo Lucijanić, Dario Rahelić, Marko Lucijanić, Hossein Gharib, Daniela Amidžić Klarić, Rajko Kušec, Vlatko Pejša, Ivica Lukšić, Tajana Štoos‐Veić and Ivan Krečak. Their work appears in journals such as International Journal of Clinical Practice, European Archives of Oto-Rhino-Laryngology, Pharmacology, International Journal of Cardiology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.